EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY Egyptian International Pharmaceutical Industries Company Stock
Equities
PHAR
EGS38081C013
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.01 EGP | -1.02% |
|
+1.58% | +4.14% |
| Sales 2024 * | 7.1B 150M | Sales 2025 * | 8.41B 178M | Capitalization | 5.65B 120M |
|---|---|---|---|---|---|
| Net income 2024 * | 874M 18.51M | Net income 2025 * | 1.08B 22.98M | EV / Sales 2024 * | 1.72 x |
| Net Debt 2024 * | 6.53B 138M | Net Debt 2025 * | 6.61B 140M | EV / Sales 2025 * | 1.46 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
6.58% | Yield 2025 * |
7.89% | Free-Float | 45.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.02% | ||
| 1 week | +1.58% | ||
| 1 month | +8.60% | ||
| 3 months | -20.81% | ||
| 6 months | -6.10% | ||
| Current year | +4.14% |
1 week
37.50
40.55
1 month
32.3340.55
Current year
32.2353.49
1 year
25.4653.49
3 years
24.5053.49
5 years
24.5079.93
10 years
24.50122.40
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-30 | 38.01 | -1.02% | 356,485 |
| 24-05-29 | 38.4 | -1.54% | 1,212,089 |
| 24-05-28 | 39 | -.--% | 746,019 |
| 24-05-27 | 39 | +4.73% | 970,384 |
| 24-05-26 | 37.24 | -0.48% | 205,500 |
End-of-day quote Egyptian Exchange, May 29, 2024
More quotes
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) specializes in manufacturing and marketing pharmaceutical products. The products include primarily antibiotics, vitamins, anesthetics and analgesics, drugs for eye care, treatment of rheumatism, gout, gastrointestinal, dermatological and cardiovascular diseases, and are administered as capsules, gels and effervescent tablets.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
38.01
EGP
Average target price
75.3
EGP
Spread / Average Target
+98.11%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.14% | 120M | |
| +15.91% | 41.97B | |
| +22.40% | 22.34B | |
| +18.48% | 15.25B | |
| +16.12% | 14B | |
| +45.12% | 12.06B | |
| -9.58% | 6.8B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B |
- Stock Market
- Equities
- PHAR Stock
